More accurate LDL-C calculation: Externally validated, guideline endorsed.

Area of Science:

• Cardiology
• Clinical Chemistry
• Preventive Medicine

Background:

• Low-density lipoprotein-cholesterol (LDL-C) is a key therapeutic target for atherosclerotic cardiovascular disease (ASCVD) prevention.
• Current European and American guidelines advocate for very low LDL-C levels (<1.8 mmol/L) in high-risk individuals.
• Accurate LDL-C determination is vital for guiding clinical decisions and therapy effectiveness, particularly at these low target levels.

Purpose of the Study:

• To compare various methods for determining LDL-C, including direct measurement and calculation-based approaches.
• To evaluate the evidence supporting these methods across diverse patient populations and fasting states.
• To identify the most accurate and widely applicable method for LDL-C measurement.

Main Methods:

• Comparative review of LDL-C measurement techniques.
• Analysis of evidence from studies involving different patient demographics.
• Assessment of method performance in both fasting and non-fasting states.

Main Results:

• The Martin/Hopkins method is identified as the preferred approach for LDL-C determination.
• This method demonstrates high accuracy and broad applicability.
• It is particularly reliable for patients with low LDL-C (<1.8 mmol/L) and elevated triglycerides (1.7-4.5 mmol/L), including those in a non-fasting state.

Conclusions:

• The Martin/Hopkins method offers superior accuracy for LDL-C measurement.
• Its reliability in non-fasting states and for challenging patient profiles (low LDL-C, high triglycerides) makes it clinically valuable.
• Accurate LDL-C assessment is essential for effective ASCVD risk management and treatment optimization.